Analyst Adam Livingston's three-year stress test of MicroStrategy (MSTR) shows the company can survive a 55% Bitcoin price crash to $26,611 despite capital markets closing and forced BTC sales to service debt. The model starts with MSTR holding 847,363 BTC and $1.4 billion cash, but as BTC price falls, senior debt claims balloon, severely compressing common shareholders' Bitcoin exposure per share. Cash runs out by month nine, forcing the sale of 115,727 BTC, yet MSTR still retains 731,636 BTC by year three, with the market NAV recovering to 1.40x. The main risk is a prolonged reduction in Bitcoin exposure for common shareholders, not immediate bankruptcy.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
